Get started
Pacira Biosciences, Inc.Pacira Biosciences, Inc.Pacira Biosciences, Inc.

Pacira Biosciences, Inc.

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsTechnicalsForecastsSeasonalsBondsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪879.54 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
53.19
Basic EPS (TTM)
0.40 EUR
Net income (FY)
‪−96.17 M‬ EUR
Revenue (FY)
‪677.12 M‬ EUR
Shares float
‪42.03 M‬
Beta (1Y)
0.87

Employees


Employees (FY)
790
Change (1Y)
+78 +10.96%
Revenue / Employee (1Y)
‪857.11 K‬ EUR
Net income / Employee (1Y)
‪−121.74 K‬ EUR

About Pacira BioSciences, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Frank D. Lee
Website
pacira.com
Headquarters
Tampa
Founded
2006
ISIN
US6951271005
FIGI
BBG0120SGRJ5
Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.

Check out other big names from the same industry as 82P.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


PCRX6079820
Pacira Biosciences, Inc. 2.125% 15-MAY-2029
Yield to maturity
—
Maturity date
May 15, 2029

See all 82P bonds 

ETFs


IJR
iShares Core S&P Small Cap ETF
Weight
0.07%
Market value
‪62.66 M‬
USD
IWM
iShares Russell 2000 ETF
Weight
0.04%
Market value
‪26.62 M‬
USD
AVUV
Avantis U.S. Small Cap Value ETF
Weight
0.14%
Market value
‪25.40 M‬
USD
VBR
Vanguard Small Cap Value ETF
Weight
0.03%
Market value
‪16.70 M‬
USD
IJS
iShares S&P Small-Cap 600 Value ETF
Weight
0.15%
Market value
‪9.45 M‬
USD
SPSM
State Street SPDR Portfolio S&P 600 Small Cap ETF
Weight
0.07%
Market value
‪9.15 M‬
USD
IWN
iShares Russell 2000 Value ETF
Weight
0.07%
Market value
‪8.43 M‬
USD
PJP
Invesco Pharmaceuticals ETF
Weight
2.22%
Market value
‪6.59 M‬
USD
SLYV
State Street SPDR S&P 600 Small Cap Value ETF
Weight
0.15%
Market value
‪5.85 M‬
USD
VTWO
Vanguard Russell 2000 ETF
Weight
0.04%
Market value
‪5.65 M‬
USD
BSVO
EA Bridgeway Omni Small-Cap Value ETF
Weight
0.31%
Market value
‪5.33 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of 82P is 20.40 EUR — it hasn't changed in the past 24 hours. Watch Pacira Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Pacira Biosciences, Inc. stocks are traded under the ticker 82P.
82P stock has risen by 12.09% compared to the previous week, the month change is a 4.62% rise, over the last year Pacira Biosciences, Inc. has showed a 31.61% increase.
We've gathered analysts' opinions on Pacira Biosciences, Inc. future price: according to them, 82P price has a max estimate of 31.18 EUR and a min estimate of 19.92 EUR. Watch 82P chart and read a more detailed Pacira Biosciences, Inc. stock forecast: see what analysts think of Pacira Biosciences, Inc. and suggest that you do with its stocks.
82P reached its all-time high on Apr 11, 2022 with the price of 75.00 EUR, and its all-time low was 10.30 EUR and was reached on Aug 12, 2024. View more price dynamics on 82P chart.
See other stocks reaching their highest and lowest prices.
82P stock is 3.00% volatile and has beta coefficient of 0.87. Track Pacira Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Pacira Biosciences, Inc. there?
Today Pacira Biosciences, Inc. has the market capitalization of ‪880.54 M‬, it has increased by 12.63% over the last week.
Yes, you can track Pacira Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Pacira Biosciences, Inc. is going to release the next earnings report on Feb 19, 2026. Keep track of upcoming events with our Earnings Calendar.
82P earnings for the last quarter are 0.60 EUR per share, whereas the estimation was 0.58 EUR resulting in a 3.32% surprise. The estimated earnings for the next quarter are 0.78 EUR per share. See more details about Pacira Biosciences, Inc. earnings.
Pacira Biosciences, Inc. revenue for the last quarter amounts to ‪152.98 M‬ EUR, despite the estimated figure of ‪154.34 M‬ EUR. In the next quarter, revenue is expected to reach ‪172.57 M‬ EUR.
82P net income for the last quarter is ‪4.63 M‬ EUR, while the quarter before that showed ‪−4.11 M‬ EUR of net income which accounts for 212.50% change. Track more Pacira Biosciences, Inc. financial stats to get the full picture.
No, 82P doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 17, 2025, the company has 790 employees. See our rating of the largest employees — is Pacira Biosciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pacira Biosciences, Inc. EBITDA is ‪124.18 M‬ EUR, and current EBITDA margin is 25.16%. See more stats in Pacira Biosciences, Inc. financial statements.
Like other stocks, 82P shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pacira Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pacira Biosciences, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pacira Biosciences, Inc. stock shows the sell signal. See more of Pacira Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.